New Guidance for High-Risk Groups The U.S. Food and Drug Administration (FDA) announced on Tuesday that it has amended its emergency use authorizations for Pfizer-BioNTech and Moderna bivalent COVID-19 vaccines. This regulatory shift allows individuals aged 65 and older, as well as those with compromised immune systems, to receive an additional booster dose ahead of…
New Guidance for High-Risk Groups The U.S. Food and Drug Administration (FDA) announced on Tuesday a significant amendment to its emergency use authorizations for Pfizer-BioNTech and Moderna bivalent COVID-19 vaccines. The regulatory update permits adults aged 65 and older, as well as individuals with specific immunocompromising conditions, to receive an additional bivalent booster dose. This…
FDA Blocks Publication of Taxpayer-Funded Vaccine Safety Studies A spokesperson for the U.S. Department of Health and Human Services (HHS) confirmed this week that the Food and Drug Administration (FDA) has blocked the publication of multiple taxpayer-funded studies that concluded Covid-19 and shingles vaccines are safe. The agency-led research, which analyzed millions of anonymized patient…